ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Are Patient-Reported Voice Outcomes Better after Surgery or after Radiation for Treatment of T1 Glottic Carcinoma?

by Michael Lupa, MD, and Ronald Amedee, MD • February 1, 2013

  • Tweet
  • Email
Print-Friendly Version

Trio Best PracticeBackground

Patients with early glottic carcinoma have several treatment options; endoscopic surgical resection and radiation therapy (XRT) are the most common choices. Both the carcinoma itself and its treatment can have an impact on voice. A variety of factors may be considered when a management plan is considered. Survival and overall organ preservation following treatment of T1 glottic carcinomas are thought to be similar between surgery and XRT. Some question remains, however, about phonatory function following treatment; other factors such as location of tumor and psychosocial considerations may also play a role in these outcomes. The objective of this review is to examine the current literature with respect to voice outcomes after treatment of T1 glottic carcinomas with surgical excision or with XRT.

You Might Also Like

  • Cost Analysis of Transoral Surgery versus XRT for Early-Stage Glottic Cancer
  • Laser Treatment Resolves Glottic Cancer in a Pilot Study
  • Patient-Reported Outcomes Assessment in the Practice Setting
  • Understanding the Minimal Clinically Important Difference in Patient-Reported Outcomes
Explore This Issue
February 2013

Intuitively, it is apparent that not all T1 tumors are equivalent with respect to voice impact, given the variety of tumor location and depth of invasion that could be included within the category of T1. Comparison of treatment modalities in terms of voice impact can be made using a variety of metrics, including patient-reported outcomes, objective acoustic measures, perceptual ratings, aerodynamic measures, and stroboscopic findings. Of these, this review focuses on patient-reported measures; these may be the most meaningful for patients facing a decision regarding treatment modality given the similarity in oncologic outcomes. The focus of this study is to summarize the current state of the literature on patient self-reported voice outcomes after treatment of T1 glottic cancers.

Conclusions

The literature to date suggests that patient-reported voice outcomes as measured by the VHI are similar whether patients with T1 glottic carcinomas are treated with endoscopic surgical resection or XRT. All of the studies with the exception of one demonstrate possible selection bias, in which treatment modalities may be differentially selected. Future efforts may focus on determining how to refine the treatment decision-making tree. Read the full article in The Laryngoscope.

Filed Under: Head and Neck, Head and Neck, Laryngology, Laryngology, Practice Focus, TRIO Best Practices Tagged With: carcinoma, voiceIssue: February 2013

You Might Also Like:

  • Cost Analysis of Transoral Surgery versus XRT for Early-Stage Glottic Cancer
  • Laser Treatment Resolves Glottic Cancer in a Pilot Study
  • Patient-Reported Outcomes Assessment in the Practice Setting
  • Understanding the Minimal Clinically Important Difference in Patient-Reported Outcomes

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.